Condition
Strabismus Surgery
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07189273Completed
Parents' Experiences of Administration Eye Drops
NCT07112157Not ApplicableNot Yet RecruitingPrimary
Efficacy of Oxalidine and Sufentanil in Strabismus Correction
NCT06929130Not Yet RecruitingPrimary
Refractive and Topographic Changes After Strabismus Surgery
Showing all 3 trials